IPSC - Century Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.56 0.02 (3.43%)	---	---	0.0 (0.0%)	0.0 (0.05%)	0.01 (1.96%)	0.0 (-0.16%)	0.0 (-0.16%)

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.38
Diluted EPS:: -0.38
Basic P/E:: -1.5234
Diluted P/E:: -1.5234
RSI(14) 1m:: 100.0
VWAP:: 0.58
RVol:: 1.1105

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.58 +0.01 (+1.56%)	Oct 15 18:24
1m	Price decrease 1m	0.57 -0.01 (-1.45%)	Oct 15 13:40
1m	Price decrease 1m	0.57 -0.01 (-1.55%)	Oct 15 12:14
1m	Price increase 1m	0.57 +0.02 (+2.99%)	Oct 15 10:05
10m	Price increase 10m	0.58 +0.02 (+3.57%)	Oct 15 09:34